Bayer's $14.2bn loan a coup for Mizuho

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Bayer's $14.2bn loan a coup for Mizuho

drugs are bad, mmmk? (right size)

Bayer, the German chemicals and pharmaceuticals firm, has signed the $14.2bn acquisition finance facility backing its purchase of Merck & Co's consumer care business.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article